HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,272,950 | +492.7% | 363,700 | +369.0% | 0.00% | – |
Q1 2024 | $214,786 | +15.6% | 77,540 | -51.6% | 0.00% | -100.0% |
Q2 2023 | $185,760 | +385.9% | 160,138 | +532.5% | 0.00% | – |
Q1 2023 | $38,230 | -88.3% | 25,318 | -80.6% | 0.00% | -100.0% |
Q4 2022 | $325,958 | -62.8% | 130,383 | -37.2% | 0.00% | -75.0% |
Q3 2022 | $877,000 | +29.9% | 207,705 | +181.1% | 0.00% | +100.0% |
Q4 2021 | $675,000 | -74.8% | 73,893 | -70.6% | 0.00% | -75.0% |
Q3 2021 | $2,683,000 | -18.4% | 251,001 | +18.5% | 0.01% | -38.5% |
Q2 2021 | $3,288,000 | +34.5% | 211,859 | +40.5% | 0.01% | -7.1% |
Q1 2021 | $2,444,000 | +654.3% | 150,745 | +590.0% | 0.01% | +250.0% |
Q3 2020 | $324,000 | -87.0% | 21,846 | -89.7% | 0.00% | -93.8% |
Q1 2020 | $2,483,000 | +32.6% | 211,531 | +165.5% | 0.06% | +481.8% |
Q4 2019 | $1,872,000 | +43.1% | 79,680 | +13.2% | 0.01% | -15.4% |
Q2 2019 | $1,308,000 | -30.9% | 70,381 | -9.1% | 0.01% | -35.0% |
Q1 2019 | $1,892,000 | -30.9% | 77,405 | -26.7% | 0.02% | -37.5% |
Q4 2018 | $2,739,000 | +10.6% | 105,584 | +34.9% | 0.03% | +6.7% |
Q3 2018 | $2,477,000 | +30.6% | 78,261 | +60.4% | 0.03% | +20.0% |
Q2 2018 | $1,896,000 | +188.6% | 48,800 | +105.0% | 0.02% | +150.0% |
Q1 2018 | $657,000 | -67.5% | 23,800 | -78.7% | 0.01% | -71.4% |
Q4 2017 | $2,020,000 | +261.4% | 111,584 | +222.4% | 0.04% | +218.2% |
Q3 2017 | $559,000 | +12.5% | 34,610 | -3.6% | 0.01% | +10.0% |
Q2 2017 | $497,000 | +4.0% | 35,913 | -1.5% | 0.01% | -50.0% |
Q4 2016 | $478,000 | +96.7% | 36,467 | +158.6% | 0.02% | +25.0% |
Q3 2016 | $243,000 | +16.8% | 14,100 | +22.6% | 0.02% | +23.1% |
Q2 2016 | $208,000 | -38.5% | 11,500 | -35.4% | 0.01% | -50.0% |
Q1 2016 | $338,000 | -36.3% | 17,800 | -10.6% | 0.03% | -55.2% |
Q4 2015 | $531,000 | – | 19,900 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |